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Abstract Neospora caninum is a protozoan parasite
predominantly known for causing abortion in cattle and
neuromuscular disease in dogs. So far, no eﬃcient
metaphylactic chemotherapy has been developed. In
preliminary studies, toltrazuril had been successfully
used against experimental neosporosis in mice and
calves. In the present study, we used immunocompetent
and immunodeﬁcient mouse strains to address the role
of immunity in supporting the chemotherapy of experi-
mental N. caninum infection. WT, lMT and athymic
nude mice were intraperitoneally inoculated with 1·106
Nc-1 tachyzoites. The drug was administered in the
drinking water for 6 consecutive days so as to obtain a
daily dose of approximately 20 mg toltrazuril/kg body
weight. The course of infection was monitored by clin-
ical, histological and immunohistochemical means, as
well as by the search for parasite DNA using PCR-
analyses of various organs. In immunocompetent WT
mice, treatment proved to be of high eﬃcacy by abro-
gation of any lesion formation or PCR-positivity in
medicated C57BL/6 mice and a signiﬁcant reduction of
lesion formation or PCR-positivity in BALB/c animals.
Similarly, treated lMT mice exhibited a signiﬁcant
reduction in cerebral lesion formation as well as in
parasite DNA detectability by PCR when compared to
untreated animals. Athymic nude mice, however, did not
respond to treatment in that only a delay of the parasite
dissemination was achieved, and nude mice still showed
the neosporosis disease symptoms, although later than
untreated animals. We conclude that treatment with
toltrazuril appears to act parasitostatically rather than
parasitocidically. This is supported by the fact that: (1)
although the lack of B-cells did not impair the eﬀect of
toltrazuril, (2) the lack of T-cells did not allow for a full
eﬃcacy of treatment. Therefore, chemotherapy with
toltrazuril against experimental infections with N. cani-
num requires the support of T-cell immunity in order to
be successful.
Introduction
The main problems associated with Neospora caninum
infections are abortion in cattle and a severe neuro-
muscular disease in dogs (Dubey 2003). Most Neospora-
induced abortions occur between 5 and 6 months of
gestation. In utero infected calves may also be born
alive, with or without clinical symptoms, but remaining
persistently infected. The outcome of neosporosis during
gestation is dependent on the time of infection or
recrudescence, among other features (Innes et al. 2000).
Vertical transmission is an important way of maintain-
ing the infection in a herd (Anderson et al. 1997; Schares
et al. 1998; Davison et al. 1999) and may occur several
times in one particular cow. The abortion risk in sero-
positive cows is four times higher than in seronegative
cows (Sager et al. 2001).
The need for the development of eﬀective pro- or
metaphylactic measures against bovine neosporosis has
been widely discussed (Liddell et al. 1999; Greif et al.
2001; Gottstein et al. 2001; Innes et al. 2002; Kritzner
et al. 2002). Eﬀective vaccines to protect cattle from
abortion on vertical parasite transmission are currently
not available (Andrianarivo et al. 2000; Innes et al.
2002). So far, quite a wide range of chemotherapeutic
agents has been tested against N. caninum. Some phar-
macologically active compounds are known to kill the
parasite in cell culture-based assays (Lindsay et al. 1994;
Dubey 2003). Recently, artemisinin and depudecin were
also found to have an anti-parasitic activity against
N. caninum in vitro (Kim et al. 2002; Kwon et al. 2003).
Oral drug treatment of mice with sulfadiazine and
amprolium was rather ineﬀective (Lindsay and Dubey
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1990b). So far, the eﬃcacy of toltrazuril and ponazuril
(triazinone derivatives) against neosporosis has been
assessed in experimentally infected immunocompetent
mice and calves (Gottstein et al. 2001; Kritzner et al.
2002). Toltrazuril was suggested to act at least against
tachyzoites, and appeared not to abrogate the develop-
ment of immunity (Greif 2000).
Experimentally, mice represent a valuable model for
the study of certain aspects of N. caninum infection.
N. caninum predominantly aﬀects the central nervous
system in mice (Lindsay et al. 1995; Yamage et al. 1996).
In acute murine neosporosis further clinical signs are
seen, such as pneumonia, myositis, encephalitis, gan-
glioradiculoneuritis and pancreatitis (Lindsay and
Dubey 1990a).
Various types of immunological deﬁciencies have
been used to assess the importance of speciﬁc compo-
nents of the immune system. Interferon-c-knockout
mice developed acute and lethal neosporosis within
2 weeks (Ritter et al. 2002). Nude mice are very sus-
ceptible to N. caninum and develop acute neosporosis
(Yamage et al. 1996; Shibahara et al. 1999). B-cell-
deﬁcient C57BL/6 (lMT) mice have also been proven
to be highly susceptible to neosporosis (Eperon et al.
1999).
The aim of the present study was to ﬁnd out whether
a humoral or cellular immune response is required to
support chemotherapy with toltrazuril. We addressed
the question experimentally using B-cell-deﬁcient (lMT)
mice and the corresponding C57BL/6 wild-type (WT)
controls, as well as athymic nude (nu)/nu)) mice and the
corresponding BALB/c WT controls.
Materials and methods
Experimental design and animals
Chemotherapy with toltrazuril against murine neospo-
rosis was carried out after Gottstein et al. (2001).
Tracking eﬃcacy was predominantly based on: (1) the
detection of parasite DNA in the brain, and (2) the
demonstration of parasite induced brain lesions—as
detected by histopathology and immunohistochemistry.
Based on our earlier experiments with mice, drug
application by drinking water was chosen (Gottstein
et al. 2001). For a daily uptake of approximately 20 mg
toltrazuril/kg body weight, 62.5 mg toltrazuril/100 ml
water was given. The average water consumption was
estimated as 0.6 ml/day for each mouse, so approxi-
mately 0.42 mg toltrazuril was ingested daily. The
weight of the mice at the beginning of the experiments
ranged from 20 to 25 g. Medication was started at the
same time as infection and was maintained for 6 days
consecutively. For experimental infection, all mice were
inoculated intraperitoneally (i.p.) with 106 Nc-1 tach-
yzoites, suspended in 200 ll PBS. Infection was per-
formed at a relatively low dose (compared to Gottstein
et al. 2001), as we anticipated the immunodeﬁcient mice
to be much more susceptible to neosporosis (assessed by
preliminary titration experiments, data not shown). All
mice were 8-week-old females. Housing and feeding
were according to the Swiss regulations on animal
experimentation.
The animals used for experimental infections in-
cluded four diﬀerent mouse strains: 24 C57BL/6 WT
mice (Harlan, Horst, The Netherlands), 19 B-cell-deﬁ-
cient lMT mice (breeding couple provided by Dr. A.
Macpherson, Institute of Experimental Immunology,
University of Zurich, Switzerland), 24 BALB/c mice and
18 athymic (nu+/nu+) BALB/c mice (both from Har-
lan).
For each mouse strain (C57BL/6 and BALB/c), a
total of 24 WT mice were used, eight of which were
infected with 106 Nc-1 tachyzoites and subjected to
toltrazuril medication. Another eight mice were simul-
taneously infected but kept without medication (see
Table 1). Four other mice served as a negative control
(no infection, no medication) and four were only treated.
In a ﬁrst attempt, 12 BALB/c athymic nude mice
were infected intraperitoneally with 106 Nc-1 tachyzo-
ites. Six of these were treated with toltrazuril as de-
scribed before while six served as controls, three with
therapy (and no infection) and three without any
Table 1 Presence of Neosporum caninum, assessed by PCR, is shown for selected organs in treated versus untreated WT mice (numbers of
PCR-positive organs per total organs are shown). Necropsy occurred at day 29 p.i.
PCR brain PCR heart PCR lung PCR liver PCR kidney PCR spleen
C57BL/6 WT mice Infection and therapy 0/8 0/8 0/8 0/8 0/8 0/8
Infection, no therapy 7/8 0/8 0/8 0/8 0/8 0/8
Controls, not infected,
with therapy
0/4 0/4 0/4 0/4 0/4 0/4
Controls, not infected,
no therapy
0/4 0/4 0/4 0/4 0/4 0/4
BALB/C WT mice Infection and therapy 2/8 0/8 0/8 0/8 0/8 0/8
Infection, no therapy 6/8 0/8 0/8 0/8 0/8 0/8
Controls, not infected,
with therapy
0/4 0/4 0/4 0/4 0/4 0/4
Controls, not infected,
no therapy
0/4 0/4 0/4 0/4 0/4 0/4
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intervention. An additional experiment, including eight
nude mice, was carried out in order to monitor the
treatment over a longer period, planned for 29 days.
An additional experiment, including eight nude mice,
was carried out in order to monitor the treatment over
a longer period, planned for 29 days.
All WT and lMT mice were killed on day 29 post-
infection (p.i.). Athymic nude mice were killed either
when the symptoms occurred (according to animal
welfare guidelines) or on day 29 p.i. Death was induced
by CO2 inhalation. Blood was taken by cardiac puncture
for serum isolation. One brain hemisphere and pieces of
heart, lung, liver, kidney and spleen were collected and
stored at –20C until PCR analysis was performed. The
other brain hemisphere was ﬁxed in PBS-buﬀered 4%
paraformaldehyde, and after paraﬃn-embedding sec-
tions were stained with haematoxylin-eosin, or used for
immunohistochemistry.
Parasites
N. caninum tachyzoites from the Nc-1 isolate (Dubey
et al. 1988) were maintained in Vero cells. The Vero cells
were cultivated in RPMI-1640 medium (Gibco, Basel,
Switzerland) supplemented with 7% fetal calf serum
(FCS), 2 mM glutamine, 50 units penicillin/ml, and
50 lg streptomycin/ml at 37C with 5% CO2 in tissue
culture ﬂasks. The tachyzoites were harvested from the
infected Vero cells by trypsination followed by repeated
passage through a 25-gauge needle. Host cell debris was
removed from the parasites by separation on Sephadex-
G25 columns as described previously (Hemphill et al.
1996). The tachyzoites were counted using a Neubauer
chamber and diluted in PBS until 200 ll contained the
above mentioned number of parasites.
DNA isolation and PCR
DNA was extracted from each sample using the DNeasy
kit (Quiagen, Basel, Switzerland) according to the
manufacturer’s recommendations. Tissues were digested
overnight, and DNA eluted followed by denaturation at
95C. PCR was done as previously described (Mu¨ller
et al. 1996) with N. caninum-speciﬁc primers Np21plus
(5¢ CCCAGTGCGTCCAATCCTGTAAC 3¢) and Np6
plus (5¢ CTCGCCAGTCAACCTACGTCTTCT 3¢) in a
thermal cycler (Gene Amp PCR System model 9700) for
40 cycles (94, 1 min; 63C, 1 min; 74C, 2.5 min). After
the last cycle, a primer extension was continued for
15 min at 72C. For each sample, the mixture with a
total volume of 25 ll contained 17.625 ll of water,
2.5 ll of 10·Gene Amp PCR buﬀer, 2.5 ll of a nucle-
otide mixture with 0.2 mM each dATP, dGTP and
dCTP, and 0.4 mM dUTP, 0.5 ll containing 20 pmol
each of Np21plus and Np6plus, 0.25 ll uracyl DNA
glycosylase (UDG) (Gibco) and 0.125 ll AmpliTaq
DNA polymerase (Perkin Elmer Cetus, Rotkreuz,
Switzerland). Pipetting the mixtures and thermal
ampliﬁcations were done in separate rooms to avoid
contamination. To prevent carry-over contamination
from previous reactions, the samples were incubated
with UDG. Prior to PCR, the reaction mixture was
initially incubated for 10 min at 20C. The UDG was
inactivated by incubation at 95C for 2 min. For each
sample, a parallel inhibition control was performed to
exclude putative false-negative results.
Serology
Mouse sera were analyzed for the presence of antibodies
against Nc-1 antigen by enzyme-linked immunosorbent
assay (ELISA) using the same somatic antigen (SA
antigen) as previously described (Gottstein et al. 2001).
An alkaline-phosphatase conjugated goat anti-mouse
IgG (Fc) was used as second antibody. Absorbance was
read at 403 nm (reference ﬁlter 630 nm) using a Dyna-
tech MR 7000 ELISA reader and the corresponding
Dynatech Biocalc software (Dynatech, Embrach, Swit-
zerland). Three standard deviations were added to the
mean of ten negative mouse controls of the respective
genetic background (no infection, no treatment). This
value served as the cut-oﬀ to discriminate between
negative and positive reactions.
Histopathology and immunohistochemistry
Tissue samples were ﬁxed in 4% neutrally buﬀered
paraformaldehyde and embedded in paraﬃn. Hema-
toxylin and eosin (HE) stained sections were analyzed by
light microscopy (LM) with the cerebellum, pons,
hipocampus, thalamus, basal ganglia and the cerebral
hemisphere being searched for lesions. These were as-
signed to one of four grades: ()) without signiﬁcant le-
sion, (+) few foci of inﬂammatory cells and small
perivascular cuﬀs, (++) moderate inﬂammation and
necrotic foci can occur, (+++) severe inﬂammation
with extensive necrosis.
For immunohistochemistry, paraﬃn sections of brain
tissue were deparaﬃnized in xylene and rehydrated in
graded methanol (100%, 90%, 70%, 50%, 30%) for
5 min at each concentration. The rehydration was fol-
lowed by a washing step with distilled water and incu-
bation in PBS. The tissues were predigested with 0.1%
pronase (protease type XXVIII, Nagarse, Sigma) in
Tris-HCl buﬀer 0.05 for 5 min at 37C. Blocking was
done with PBS containing 1.5% bovine serum albumin
(BSA) and 50 mM glycine (blocking buﬀer) for 2 h at
room temperature in a humid chamber. The sections
were washed three times in PBS, each time for 5 min. A
polyclonal rabbit-anti-N. caninum antibody (Gottstein
et al. 2001) was applied as primary antibody at a dilution
of 1:250 in a blocking buﬀer (PBS with 1.5% BSA) for
1.5 h at room temperature in a humid chamber. After
three washings in PBS of 5 min each, goat anti-rabbit
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FITC (Sigma) was applied as second antibody at a
dilution of 1:100 in blocking buﬀer (PBS with 1.5%
BSA) for 30 min. The slides were washed again three
times in PBS for 5 min. The samples were incubated in
the ﬂuorescent dye Hoechst 33258 (1:300 in PBS) for
2 min, rinsed again in PBS and mounted in Fluoroprep
(BioMerieux, Geneva, Switzerland). The slides were
analyzed on a Leitz Laborlux S ﬂuorescence microscope
and the severity of infection was classiﬁed as follows: ())
no parasites, (+) less than 20 parasites, (++) 20–200
parasites and (+++) more than 200 parasites per slide.
Sections stained with HE were analyzed by LM (per
mouse and brain), and an adjacent section was used for
immunohistochemistry.
Chemotherapy
Medication with toltrazuril (Baycox, Bayer) was given
via the drinking water for 6 consecutive days. The nor-
mal water was replaced by water containing the drug
just after infection. To yield a daily uptake of 20 mg/kg
BW, 62.5 mg toltrazuril/100 ml water was given. The
average water consumption was estimated as 0.6 ml/day
for each mouse, so that approximately 0.42 mg toltr-
azuril was ingested daily. The weight of the mice at
infection ranged between 20 and 25 g. Optimal admin-
istration and dose had been assessed previously (Gott-
stein et al. 2001).
Results
Neospora-PCR
None of the WT mice showed any clinical symptoms
until death. Brain, heart, lung, liver, kidney and spleen
samples of WT mice were analyzed by PCR (Table 1).
Parasite DNA was not detected in any of the organs of
the infected and medicated groups of C57BL/6 mice. In
the BALB/c animals, two out of eight were PCR posi-
tive. Conversely, in mice that were infected but not
medicated, PCR yielded a positive result in the brains of
seven out of eight animals for the C57BL/6-strain and
six out of eight for the BALB/c-strain. In the brain-
positive animals, all other organs were free of detectable
parasite DNA. All uninfected control mice were com-
pletely negative by PCR examination.
Of the 19 lMT mice investigated, eight were infected
and treated with toltrazuril (Table 2). Eight other mice
were infected with the same dose but received no medi-
cation. Three mice served as negative controls (no
infection, no treatment). One mouse from the untreated
group died 26 days after infection. All other mice were
killed 29 days after infection. None of the animals
showed any clinical symptoms. All individuals from the
infected and treated group were completely negative by
PCR, as parasite DNA remained undetected in any of
the brains or other organs. Conversely, N. caninum
DNA was detected in all brains of the infected and un-
treated mice. One mouse had an additional positive PCR
result in the heart and the lungs, four in the lungs and
one in the kidneys. All control mice were completely
negative by PCR.
The presence of N. caninum, assessed by PCR, in
selected organs in treated versus untreated athymic nude
mice is shown in Table 3. Two untreated BALB/c ani-
mals died 14 days after infection. One mouse was ill at
this time and died 15 days after infection. The remaining
three untreated mice also became sick and were there-
fore killed. The mice showed clinical signs, including
shivering, a bent back, neurological symptoms and
apathy. They were thin, and at necropsy no intraperi-
toneal fat was found. No symptoms were seen in con-
trol-treated animals and untouched controls. Five
treated mice and ﬁve controls were killed on the same
day as the untreated mice in order to compare the dif-
ferent groups at the same stage of infection. Of the eight
treated mice in the second experimental nude mouse
group, three died prematurely on day 26 p.i. and two
after 27 days. The remaining three mice were killed
28 days after infection because they were apathic and
thin. In the ﬁrst series of nude mice killed on day 15 p.i.,
only one out of ﬁve infected and treated animals had a
positive PCR result, whereas all six infected mice with-
out therapy had detectable parasite DNA in their brains.
The parasite was also found in several mice of both
groups. The heart was aﬀected in four treated and four
untreated mice and the lungs of all infected animals were
also infected. The liver and kidneys were less aﬀected in
treated than in untreated mice. As expected, all of the six
uninfected control mice were negative by PCR analysis.
In the second experimental series with nude mice, par-
asite DNA was detected in seven out of eight mice.
Except for one mouse with a negative brain PCR, which
nevertheless had detectable DNA in the heart, the par-
asite was detected in every other organ examined.
Table 2 Presence of N. caninum, assessed by PCR, in selected organs in treated versus untreated antibody-deﬁcient lMTmice (numbers of
PCR-positive organs per total rgans are shown). Necropsy occurred at day 29 p.i. One mouse died 26 days p.i. in the infection no therapy
group, samples from the organs of which were also included
lMT mice PCR brain PCR heart PCR lung PCR liver PCR kidney PCR spleen
Infection and therapy 0/8 0/8 0/8 0/8 0/8 0/8
Infection, no therapy 8/8 1/8 5/8 0/8 1/8 0/8
Controls, not infected,
untreated
0/8 0/8 0/8 0/8 0/8 0/8
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Comparing the treated mice with the untreated mice at
15 days p.i., the infection appeared more widespread in
untreated mice than in medicated animals. After
29 days, this eﬀect was abrogated in that the infection
appeared more or less identically spread in the whole
body of all animals in both mouse groups.
ELISA
All WT mice (of both strains) inoculated with N. cani-
num had produced antibodies in response to infection.
ELISA results are shown in Fig. 1. The mice that had
received toltrazuril treatment developed signiﬁcantly
lower antibody concentrations than the untreated mice.
These observations are in line with earlier ﬁndings
(Gottstein et al. 2001).
lMT (B-cell-deﬁcient) and nude (T-cell-deﬁcient)
mice are incapable of antibody production. As expected,
all results of the ELISA were below the cut-oﬀ value,
thus none of these mice produced any antibody response
(data not shown).
Histology
Three HE-stained coronary sections taken at three dif-
ferent levels from each mouse brain (from all strains)
were analyzed by LM. All sections were histologically
classiﬁed into four grades according to the pathological
ﬁndings (Figs. 2, 3). For the C57BL/6 WT mice, no le-
sions or inﬂammation were visible in any samples from
the medicated animals, whereas two of the eight BALB/c
mice exhibited a few foci of inﬂammation (Table 4).
Conversely, in C57BL/6 WT mice without therapy, foci
with slight to moderate inﬂammation were detected in
all brains, and in six of eight BALB/c mice necrosis/
inﬂammation was apparent. As expected, the brains
from control mice (medicated and untreated) were free
from any signs of inﬂammation.
Slight lesions were found in three lMT treated mice,
including mainly foci with inﬂammatory cells and peri-
vascular cuﬀs. The other ﬁve mice were within normal
limits. In one mouse from the untreated group, slight
lesions were found. One mouse showed moderate lesions
with more widespread foci of inﬂammation. Five mice
had severe lesions with inﬂammation and necrosis. No
pathology was observed in any of the control mice.
Three out of nine treated nude mice showed no his-
tological sign of inﬂammation in the brain, while six
mice exhibited mild lesions with accumulations of a few
inﬂammatory cells. The lesions and inﬂammation were
found in all six untreated mice. In four mice, a mild
inﬂammation was present, two other mice showed
moderate lesions and inﬂammation. Severe inﬂamma-
tion with widespread necrotic foci were not found in any
of these nude mice. No signiﬁcant lesion was detected in
any of the uninfected control animals.
Fig. 1 Mean antibody reactivities (±SE) in WT mice determined
by ELISA. White bars refer to C57BL/6 and grey bars to BALB/c
WT mice. A and B represent uninfected control mice, including
both untreated and toltrazuril treated animals. C and D represent
infected and toltrazuril-treated mice, E and F infected and
untreated animals. * and # indicate statistically signiﬁcant
diﬀerences between the respective groups of the respective strain,
at P £ 0.05 (Student’s t-test). The diﬀerence between D and F was
not signiﬁcant (P=0.27)
Table 3 Presence of N. caninum, assessed by PCR, in selected or-
gans in treated versus untreated athymic nude mice (numbers of
PCR-positive organs per total organs are shown). Necropsy oc-
curred at day 29 p.i. Three mice from the infection and therapy
group (day 29) died prematurely on day 26 p.i. and two after
27 days p.i. The remaining three mice were killed 28 days after
infection because they showed severe clinical signs of neosporosis.
Thus, no nude mouse reached the planed time span of 29 days p.i.
Athymic nude mice PCR brain PCR heart PCR lung PCR liver PCR kidney PCR spleen
Infection and therapy 1/5 4/5 5/5 1/5 1/5 3/5
Necropsy 15 days p.i.
Infection, no therapy 6/6 4/6 6/6 4/6 4/6 6/6
Necropsy 15 days p.i.
Controls, not infected,
with therapy
0/3 0/3 0/3 0/3 0/3 0/3
Necropsy 29 days p.i.
Controls, not infected,
untreated
0/3 0/3 0/3 0/3 0/3 0/3
Necropsy 29 days p.i.
Infection and therapy 7/8 5/5 4/5 3/4 3/4 3/4
Necropsy planed 29 days p.i.
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Immunohistochemistry
All sections were immunohistochemically attributed to
one of four grades according to the parasite numbers
detected, as exempliﬁed in Fig. 4. Parasites were not
detected by immunohistochemistry in any of the
treated C57BL/6 WT mice or six out of eight treated
BALB/c WT mice (Table 5). Single tachyzoites were
found in two out of eight C57BL/6 WT mice and
three out of eight BALB/c mice from the untreated
groups. All uninfected control mice were free from
parasites.
Fig. 2A–D Histology of
Neospora caninum-infected
murine (lMT) brains, HE
staining, 200·. A Uninfected
control ()); B mild
inﬂammation with perivascular
cuﬀs (+); C moderate
inﬂammation (++); D
widespread necrosis (+++)
Fig. 3A–D Histology of N.
caninum-infected murine (lMT)
brains, H-E staining, 400·. A
Uninfected control ()); B slight
inﬂammation with perivascular
cuﬀs (+); C moderate
inﬂammation (++); D severe
inﬂammation (+++)
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In one treated lMT mouse, a few single tachyzoites
were seen with immunohistochemistry, despite the neg-
ative PCR results. The other treated mice were all neg-
ative; no tachyzoites could be seen. Three of the
untreated mice showed the presence of a few tachyzoites
in the brain, another three mice had a moderate infec-
tion intensity in brain, and in one mouse more than 200
tachyzoites were detected per section. All uninfected
control lMT mice yielded negative results.
Immunohistochemistry of nude mouse brains re-
vealed the same tendency as found using histology.
Three out of nine treated mice had no detectable para-
sites in the brain. In two mice, just a few parasites were
found, and a moderate number of parasites was seen in
only one mouse. Conversely, infection became apparent
in most of the seven untreated nude mice: in four mice
with few and in one mouse with a moderate number of
Table 4 Assessment of the extent and severity of cerebral lesions
related to N. caninum infection in H-E stained sections from
N. caninum-infected C57BL/6 WT and BALB/C (eight treated
versus eight untreated per strain), lMT (eight treated versus seven
untreated), and nude (nine treated versus six untreated) mice: ())
no lesions; (+) mild inﬂammation; (++) moderate inﬂammation
and few small necrotic foci; (+++) severe inﬂammation and
extensive necrosis
) + ++ +++
C57BL/6 WT mice with toltrazuril
therapy
8 ) ) )
Untreated C57BL/6 WT mice ) 5 3 )
BALB/C WT mice with toltrazuril
therapy
6 2 ) )
Untreated BALB/C WT mice 2 3 3 )
lMT mice with toltrazuril therapy 5 3 ) )
Untreated lMT mice ) 1 1 5
Nude mice with toltrazuril therapy 3 6 ) )
Untreated nude mice ) 4 2 )
Fig. 4A–D Immunohisto-
chemical investigation of
N. caninum-infected murine
(lMT) brains, using a
polyclonal rabbit anti-
N. caninum hyperimmune
serum and an FITC-labelled
second antibody; 600·.
A Uninfected control ());
B mild invasion with
tachyzoites (+); C moderate
invasion with tachyzoites (++);
D severe invasion with
tachyzoites (+++)
Table 5 Assessment of the extent and severity of cerebral lesions
related to N. caninum infection after immunohistochemistry from
N. caninum-infected treated versus untreated C57BL/6 WT, lMT
and nude mice (the same animals as listed in Table 4): ()) no le-
sions; (+) mild inﬂammation; (++) moderate inﬂammation and
few small necrotic foci; (+++) severe inﬂammation and extensive
necrosis
) + ++ +++
C57BL/6 WT mice with
toltrazuril therapy
8 ) ) )
Untreated C57BL/6 WT mice 6 2 ) )
BALB/C WT mice with
toltrazuril therapy
6 2 ) )
Untreated BALB/C WT mice 5 3 ) )
lMT mice with toltrazuril therapy 7 1 ) )
Untreated lMT mice ) 3 3 1
Nude mice with toltrazuril
therapy
6 2 1 )
Untreated nude mice 1 4 1 )
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detectable parasites. All uninfected controls were free
from parasites.
Discussion
The results of the present study show that the elimina-
tion of the parasite can only be achieved in mice with an
intact cell-mediated immune system. Thus, all untreated
WT mice became infected but without exhibiting any
clinical symptoms. We had expected this, as we had
opted for a relatively low infection dose in anticipation
of a higher susceptibility to infection in immune com-
promised mice. Following necropsy, parasite DNA was
nevertheless detected by PCR in all of the brains of
C57BL/6 WT mice and most of the BALB/c WT mice,
but not in the other organs of the infected and untreated
mice. Most untreated WT mice had slight to moderate
non-suppurative, multifocal encephalitis. Immunohisto-
chemistry did not reveal parasites in all brains with
HE-detected lesions, but, conversely, all brains with
detectable parasites also had detectable lesions.
Methodically, one brain hemisphere was taken for PCR
analysis, while the other half served for histological and
immunohistochemical investigation. As mentioned pre-
viously, the distribution of parasites and associated le-
sions can vary between diﬀerent locations in the brain
(Gottstein et al. 2001; Sager et al. 2001). This may ex-
plain the lack of PCR-ampliﬁable DNA despite the
presence of histological ﬁndings in, for example, one
untreated WT mouse that was negative by PCR but that
had lesions in the brain.
Long et al. (1998) reported that both BALB/c and
C57BL/6 mice exhibited similar high numbers of brain
lesions and intracerebral tachyzoites when compared
to B10.D2 mice. In our study, infection resulted in a
higher parasite load in the brains in BALB/c when
compared to C57BL/6 mice, for both untreated and
treated animals (as shown by PCR, histology and
immunohistochemistry). In treated WT C57BL/6 mice,
the parasite did not damage the brain because neither
lesions nor parasites were detected upon histological
examination, whereas two out of eight treated
WT BALB/c mice were not completely cleared by
toltrazuril.
Therapy did not aﬀect the parasite before immuno-
competent mice mounted an antibody response. This,
however, was signiﬁcantly weaker in treated than in
untreated animals. These ﬁndings conﬁrmed previous
observations (Greif 2000; Gottstein et al. 2001; Kritzner
et al. 2002). Toltrazuril does not appear to exhibit an
immediate knockdown eﬀect, thus requiring the immune
system to become active against the parasite. Never-
theless, the tachyzoites were probably eliminated before
having invaded the brain. In untreated animals, the
infection was also clinically contained, although brain
damage was not completely prevented and a few single
tachyzoites were visible by immunoﬂuorescence in one
untreated mouse.
One untreated lMT mouse died 26 days p.i.; the rest
of the animals showed no clinical signs at the day of
necropsy. Similarly, in a previous experiment lMT mice
infected with 105 Nc-1 tachyzoites had started to die
after 29 days p.i. (Eperon et al. 1999). N. caninum DNA
was detected by PCR in all brains and most of the or-
gans, as also found by Eperon et al. (1999). In infected
lMT mice that had received toltrazuril treatment, no
N. caninum DNA was detected by PCR in any of the
organs. As expected, no antibodies to N. caninum anti-
gen were detected in any lMT mouse. Consequently,
toltrazuril seems to be eﬃcient in reducing the dissemi-
nation of tachyzoites even in the absence of antibodies,
although a few tachyzoites were also detected by
immunohistochemistry in one treated and PCR-negative
lMT mouse. This may be related to a topographically
uneven distribution of the few remaining parasites.
Nevertheless, in seven out of eight treated mice no
parasites were found by immunoﬂuorescence, whereas
parasites were seen in all of the untreated mice.
In untreated mice, the lack of B-cell immunity was
in line with a complete failure to control the infection
(Eperon et al. 1999), thus indicating that antibodies
may play a crucial role in the control of infection.
Following treatment with toltrazuril, lMT mice seemed
to be able to control infection up to the point that,
despite the presence of some parasites in the brain in a
few cases, no widespread inﬂammation or necrosis was
induced. The results obtained with lMT mice demon-
strate that toltrazuri -treatment can apparently act in
an antibody independent manner. Whether cellular
immune mechanisms support the chemotherapeutical
eﬀect in clearing the infection is not deducible from
these experiments. This question was subsequently
addressed with experiments carried out using athymic
nude mice.
In previous experiments, we showed that athymic
nu)/nu) mice exhibit a very high susceptibility to
infection and disease (Yamage et al. 1996). In the pres-
ent experiments, the parasite could be found in all or-
gans of most of the untreated mice at day 15 p.i. At this
time, the brain of most treated nude mice was still free of
parasites (assessed by PCR and immunohistochemistry).
Nevertheless, the parasites had not been eliminated, as
tachyzoites remained, e.g. detected in most lungs and
hearts. Repeating the experiments with a longer time
span after treatment tested the parasite survival
hypothesis, in that mice stared to die upon day 26 p.i.,
thus we decided to kill all animals on day 28 p.i. Nev-
ertheless, medicated nude mice survived markedly longer
than untreated animals. From these experiments we can
conclude that a 6-day toltrazuril treatment has a par-
asitostatic rather than a parasitocidic eﬀect. Compared
to WT or lMT mice, the periparasitic host reaction was
signiﬁcantly lower in nude mice. Thus, only a mild
polymorphonuclear inﬂammation was present. Clusters
of parasites were found intracellularly and extracellu-
larly in several mice by LM. Thick-walled cysts were
never observed. Toltrazuril is not eﬃcient at preventing
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neosporosis in nude mice. Although it delays the out-
break of disease, it cannot inhibit the spread of tach-
yzoites. Infection with 106 Nc-1 tachyzoites is fatal for
athymic nude mice.
The results obtained with athymic nu)/nu) mice
demonstrate conclusively that toltrazuril can not clear
the infection, but that its use resulted in a marked delay
of parasite dissemination and disease in this T-cell-
deﬁcient host. T-cells thus seem to play a crucial role in
protection against N. caninum. Also, interferon-c and
interleukin-12 knockout mice exhibited a high suscepti-
bility to acute neosporosis (Khan et al. 1997; Baszler
et al. 1999; Nishikawa et al. 2001).
Toltrazuril is eﬀective against experimental infec-
tions with N. caninum in mice. Experimental infection
of susceptible lMT mice indicated that an antibody
response is not required to support the eﬀect of medi-
cation. Conversely, T-cell immunity is essential to bring
the infection under control. An eﬀect of toltrazuril on
tachyzoites is demonstrated by the delayed spread of
the parasite and the longer survival of treated athymic
nude mice. Therefore, we conclude that a parasitostatic
eﬀect of toltrazuril occurs that requires the accompa-
niment of T-cell immunity to evoke its full eﬀect. So
far, the application of toltrazuril has not been tested in
naturally occurring acute or chronic infections. Future
experiments will therefore also have to address the
stage speciﬁcity of chemotherapy, as well as host
speciﬁcity.
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